The NIF3L1 (NGG1-interacting factor 3-like 1) antibody is a tool used to study the NIF3L1 protein, encoded by the *NIF3L1* gene in humans. This evolutionarily conserved protein is ubiquitously expressed and implicated in diverse cellular processes, including transcriptional regulation, cell cycle control, and stress response. Structurally, NIF3L1 contains a NIF3-type domain, suggesting its role in protein-protein or protein-nucleic acid interactions. While its exact molecular mechanisms remain under investigation, studies link NIF3L1 to chromatin remodeling complexes and DNA damage response pathways. It may act as a scaffold or modulator in signaling networks, influencing gene expression and cellular homeostasis.
Antibodies targeting NIF3L1 enable researchers to explore its expression patterns, subcellular localization (primarily nuclear), and interactions in model systems. These antibodies are critical for techniques like Western blotting, immunofluorescence, and immunoprecipitation. Dysregulation of NIF3L1 has been tentatively associated with cancers and neurological disorders, though functional studies are ongoing. Commercial NIF3L1 antibodies are typically validated in species like human, mouse, and rat, with applications spanning basic research and disease mechanism studies. Researchers prioritize antibodies with high specificity, often verified via knockout controls, to ensure reliability in detecting this moderately characterized protein.